The full milestone payments would only be paid if a drug candidate made it all the way to market. That's at least five years away even if one of these development partnerships is a roaring success.
But even so, one out of three coming good over the next five years would still produce a very nice result.
Add to My Watchlist
What is My Watchlist?
